Cognitive Factors for Predicting Treatment Response in Schizophrenic Patients: One-Year Follow-Up Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: This study was conducted to investigate the cognitive factors that can longitudinally predict the response to treatment in patients with schizophrenia. Methods: The subjects were 49 patients with schizophrenia who were newly hospitalized in an acute psychiatry ward and had not been treated with medication for at least 8 weeks prior to the study. The symptoms and cognitive functions of the patients were evaluated at baseline before treatment (T0), at eight weeks after treatment (T1), and one year after treatment (T2). Clinical symptoms were assessed using the PANSS, and cognitive functions were estimated using the Vigilance Test, Cognitrone Test, Wisconsin Card Sorting Test (WCST), and the Korean version of the Memory Assessment Scales (K-MAS). Results: The patient group showed marked impairments in cognitive function when compared to the normal group, but the patients’ clinical symptoms and cognitive functions improved after drug treatment. The patients also showed consistent improvement in verbal and nonverbal memory function as time progressed. Furthermore, there was a significant correlation between clinical symptoms and cognitive functions in the patient group. The cognitive variables that best predicted treatment response and prognosis were total errors on the WCST and immediate list recall component of the K-MAS. It was also shown that the number of total errors on the WCST was a better cognitive predictor than the number of errors in immediate recall. Conclusion: The results of the present study show that the neurocognitive functions of patients with schizophrenia can be stabilized with treatment intervention, that treatment response is related to improvement in cognitive function, and that cognitive domains, especially executive function, can predict treatment response and prognosis in patients with schizophrenia.
Abstract
Objective: This study was conducted to investigate the cognitive factors that can longitudinally predict the response to treatment in patients with schizophrenia. Methods: The subjects were 49 patients with schizophrenia who were newly hospitalized in an acute psychiatry ward and had not been treated with medication for at least 8 weeks prior to the study. The symptoms and cognitive functions of the patients were evaluated at baseline before treatment (T0), at eight weeks after treatment (T1), and one year after treatment (T2). Clinical symptoms were assessed using the PANSS, and cognitive functions were estimated using the Vigilance Test, Cognitrone Test, Wisconsin Card Sorting Test (WCST), and the Korean version of the Memory Assessment Scales (K-MAS). Results: The patient group showed marked impairments in cognitive function when compared to the normal group, but the patients’ clinical symptoms and cognitive functions improved after drug treatment. The patients also showed consistent improvement in verbal and nonverbal memory function as time progressed. Furthermore, there was a significant correlation between clinical symptoms and cognitive functions in the patient group. The cognitive variables that best predicted treatment response and prognosis were total errors on the WCST and immediate list recall component of the K-MAS. It was also shown that the number of total errors on the WCST was a better cognitive predictor than the number of errors in immediate recall. Conclusion: The results of the present study show that the neurocognitive functions of patients with schizophrenia can be stabilized with treatment intervention, that treatment response is related to improvement in cognitive function, and that cognitive domains, especially executive function, can predict treatment response and prognosis in patients with schizophrenia.
참고문헌 (50)
- Muller BW, "Neuropsychological Deficits and Concomitant Clinical Symptoms in Schizophrenia", European Psychologist, 9, pp.96~106 (2004)
- Bilder RM, "Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration", Schizophr Bull, 18, pp.437~448 (1992)
- Abrahamson D, "Schizophrenic deterioration", Br J Psychiatry, 143, pp.82~83 (1983)
- Silverberg-Shalev R, "Selective language deterioration in chronic schizophrenia", J Neurol Neurosurg Psychiatry, 44, pp.547~551 (1981)
- Sweeney JA, "Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia", Schizophr Bull, 18, pp.283~293 (1992)
- Sweeney JA, "Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study", Psychiatry Res, 38, pp.63~76 (1991)
- Bilder RM, "Neuropsychological deficits in the early course of first episode schizophrenia", Schizophr Res, 5, pp.198~199 (1991)
- Hoff AL, "Neuropsychological functioning of first-episode schizophreniform patients", Am J Psychiatry, 149, pp.898~903 (1992)
- Nopoulos P, "Stability of cognitive functioning early in the course of schizophrenia", Schizophr Res, 14, pp.29~37 (1994)
- Goldberg TE, "The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia", Br J Psychiatry, 162, pp.43~48 (1993)
- Norman RM, "Symptoms and cognition as predictors of community functioning: a prospective analysis", Am J Psychiatry, 156, pp.400~405 (1999)
- Green M, "Neuropsychological performance and positive and negative symptoms in schizophrenia", J Abnorm Psychol, 94, pp.460~469 (1985)
- Liddle PF, "Schizophrenic syndromes, cognitive performance and neurological dysfunction", Psychol Med, 17, pp.49~57 (1987)
- Censits DM, "Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study", Schizophr Res, 24, pp.289~298 (1997)
- Hoff AL, "Longitudinal neuropsychological follow-up study of patients with firstepisode schizophrenia", Am J Psychiatry, 156, pp.1336~1341 (1999)
- Lysaker PH, "Bioty SM", J Nerv Ment Dis, 183, pp.332~336 (1995)
- Smith RC, "Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients", Compr Psychiatry, 33, pp.139~145 (1992)
- Robinson DG, "Koreen A, Sheitman B, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder", Am J Psychiatry, 156, pp.544~549 (1999)
- Chen EY, "A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients", Schizophr Res, 77, pp.99~104 (2005)
- Green MF, "What are the functional consequences of neurocognitive deficits in schizophrenia?", Am J Psychiatry, 153, pp.321~330 (1996)
- Green MF, "Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?", Schizophr Bull, 26, pp.119~136 (2000)
- P, version 2.0), "Structured clinical Interview for DSM-IV Axis I Disorder- Patient Edition (SCID-I", pp.1998, First M
- Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Lee C, "Korean standardization study of the vienna test system for clinical use (I): standard progressive matrices test of students in Seoul", J Korean Neuropsychiatr Assoc, 32, pp.252~258 (1993)
- S Vienna test system: The Universal System for computer-aided diagnostics and therapy in psychology and medicine, "The PC", pp.1988, Schfried G
- Lee HS, "A Preliminary Study on Standardization of K-MAS (Korean version of Memory Assessment Scales)", Kor J Clin Psychol, 18, pp.221~241 (1999)
- Williams JM, "Memory Assessment Scales" (1991), Psychological Assessment Resources
- Little MM, "Clinical memory tests and everyday memory", Arch Clin Neuropsychol, 1, pp.323~333 (1986)
- Lezak MD, "Neuropsychological assessment" (1995), Oxford University Press
- Heaton RK, "Wisconsin Card Sorting Test Manual: revised and expanded" (1993), Psychological Assessment Resources
- Stip E, "Discriminant cognitive factors in responder and non-responder patients with schizophrenia", Eur Psychiatry, 14, pp.442~450 (1999)
- Chaikelson JS, "Cognitive changes with aging in schizophrenia", J Clin Psychol, 39, pp.25~30 (1983)
- Russell AJ, "Schizophrenia and the myth of intellectual decline", Am J Psychiatry, 154, pp.635~639 (1997)
- Woods BT, "Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism", Am J Psychiatry, 155, pp.1661~1670 (1998)
- Stordal KI, "General psychopathology is more important for executive functioning than diagnosis", Acta Psychiatr Scand, 111, pp.22~28 (2005)
- Breier A, "National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome", Arch Gen Psychiatry, 48, pp.239~246 (1991)
- Capleton RA, "Cognitive function in schizophrenia: ass", Psychol Rep, 78, pp.123~128 (1996)
- Berman I, "Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia", Schizophr Res, 25, pp.1~10 (1997)
- Addington J, "Neurocognitive and social functioning in schizophrenia", Schizophr Bull, 25, pp.173~182 (1999)
- Addington J, "Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study", Schizophr Res, 44, pp.47~56 (2000)
- Lysaker P, "Wisconsin card sorting test and work performance in schizophrenia", Psychiatry Res, 56, pp.45~51 (1995)
- Lysaker PH, "Social skills at work. Deficits and predictors of improvement in schizophrenia", J Nerv Ment Dis, 183, pp.688~692 (1995)
- Heydebrand G, "DeLisi LE Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia", Schizophr Res, 68, pp.1~9 (2004)
- Cirillo MA, "Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms", Neuropsychol Rev, 13, pp.43~77 (2003)
- Zihl J, "Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder", Acta Psychiatr Scand, 97, pp.351~357 (1998)
- Franke P, "Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?", Schizophr Res, 6, pp.243~249 (1992)
- Bellack AS, "Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies", Schizophr Bull, 25, pp.257~274 (1999)
- Green MF, "Should schizophrenia be treated as a neurocognitive disorder?", Schizophr Bull, 25, pp.309~319 (1999)
- Andreasen NC, "Positive and negative symptoms in schizophrenia. A critical reappraisal", Arch Gen Psychiatry, 47, pp.615~621 (1990)
- Cole JO, "Drugs in the treatment of psychosis: controlled studies. Psychiatric drugs", pp.153~180 (1966), Grune and Statton